Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
Christine Johnston, Elizabeth R. Brown, Jenell Stewart, et al.
EClinicalMedicine (2021) Vol. 33, pp. 100773-100773
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
ESCMID COVID-19 living guidelines: drug treatment and clinical management
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 222-238
Open Access | Times Cited: 139
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection
Catherine E. Oldenburg, Benjamin A. Pinsky, Jessica Brogdon, et al.
JAMA (2021) Vol. 326, Iss. 6, pp. 490-490
Open Access | Times Cited: 116
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Charan Thej Reddy Vegivinti, Kirk W. Evanson, Hannah Lyons, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 93
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Timothy S.C. Hinks, Lucy Cureton, Ruth Knight, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 79
Antibiotics for the treatment of COVID-19
Maria Popp, Miriam Stegemann, Manuel Riemer, et al.
Cochrane library (2021) Vol. 2022, Iss. 7
Open Access | Times Cited: 77
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trials
Ahmed Kamel, Mona S. Abdel Monem, Nour A. Sharaf, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 1
Open Access | Times Cited: 49
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 45
Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials
Jenell Stewart, Meighan Krows, Torin Schaafsma, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2148325-e2148325
Open Access | Times Cited: 36
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial
Álvaro Avezum, Gustavo B.F. Oliveira, Haliton Alves de Oliveira, et al.
The Lancet Regional Health - Americas (2022) Vol. 11, pp. 100243-100243
Open Access | Times Cited: 34
Outpatient randomized controlled trials to reduce COVID‐19 hospitalization: Systematic review and meta‐analysis
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 19
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy
Mina Kelleni
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111626-111626
Open Access | Times Cited: 38
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Chenyang Zhang, Huaqing Jin, Yi Feng Wen, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 38
Fractal-fractional order mathematical vaccine model of COVID-19 under non-singular kernel
Ebrahem A. Algehyne, Muhammad Ibrahim
Chaos Solitons & Fractals (2021) Vol. 150, pp. 111150-111150
Open Access | Times Cited: 36
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 1837-1885
Open Access | Times Cited: 33
Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials
Natàlia Casamitjana, Gilmar Reis, David R. Boulware, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 3, pp. 524-535
Open Access | Times Cited: 10
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Megan Crichton, Pieter Goeminne, Krizia Tuand, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210171-210171
Open Access | Times Cited: 24
Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trials
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 16
Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules
Chunye Zhang, Ming Yang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6083-6083
Open Access | Times Cited: 15
Care for adults with COVID ‐19: living guidelines from the National COVID ‐19 Clinical Evidence Taskforce
Heath White, Steve McDonald, Bridget E. Barber, et al.
The Medical Journal of Australia (2022) Vol. 217, Iss. 7, pp. 368-378
Open Access | Times Cited: 14
Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic
David J. H. Bian, Siham Sabri, Bassam Abdulkarim
Cancers (2022) Vol. 14, Iss. 15, pp. 3598-3598
Open Access | Times Cited: 13
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Shota Yanagida, Ayano Satsuka, Sayo Hayashi, et al.
Toxicological Sciences (2021) Vol. 183, Iss. 1, pp. 227-239
Open Access | Times Cited: 17
Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
Shashank Joshi, Agam Vora, K Venugopal, et al.
Pragmatic and Observational Research (2022) Vol. Volume 13, pp. 33-41
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top